Send us Feedback

Omrix Biopharmaceuticals (OMRI)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW
 
 
 
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
Balance Sheet    (USD)
Annual | Quarterly
QUARTER ENDING 30-SEP
2007		 31-DEC
2007		 31-MAR
2008		 30-JUN
2008		 30-SEP
2008
Cash & Equivalents 17.5M 25.9M 27.2M 40.5M 47.3M
Short Term Investments 67.9M 55.0M 55.4M 42.6M 33.2M
Accounts Receivable 15.3M 23.1M 22.0M 22.4M 26.5M
Inventories 21.7M 20.5M 22.0M 21.7M 19.6M
Pre-paid Expenses 1.44M 963K 2.64M 2.35M 1.14M
Deferred Tax Assets 0 0 0 0 0
Other Current Assets 0 661K 0 0 0
Total Current Assets 124M 126M 129M 130M 128M
Property, Plant & Equipment 12.2M 14.9M 19.8M 21.0M 24.8M
Goodwill & Intangibles 0 1.53M 0 0 0
Other Long-term Assets 2.78M 2.77M 4.19M 3.07M 2.75M
Total Long-Term Assets 15.0M 19.2M 24.0M 24.1M 27.6M
Accounts Payable 7.43M 7.47M 20.6M 9.19M 8.21M
Accrued Expenses 7.07M 0 0 0 0
Short Term Debt 629K 0 0 0 0
Long Term Debt 0 782K 0 0 0
Capital Lease Obligations 0 0 0 0 0
Deferred Income Tax 0 0 0 0 0
Other Long-term Liabilities 9.69M 10.2M 10.5M 10.3M 9.46M
Minority Interest 0 0 0 0 0
Total Liabilities 24.8M 26.7M 31.1M 28.0M 26.2M
Preferred Stock 0 0 0 0 0
Common Par 169K 170K 171K 171K 171K
Additional Paid-In Capital 177M 178M 179M 180M 180M
Retained Earnings -60.4M -57.1M -55.0M -52.0M -48.4M
Treasury Stock -44.0K -44.0K -44.0K -44.0K -44.0K
Other Equity -2.47M -2.39M -2.17M -2.23M -3.01M
Total Shareholder's Equity 114M 119M 122M 126M 129M
⟩





⟩





⟩





⟩





⟩





⟩





⟩
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
 
⟩





⟩





⟩





⟩





⟩





⟩





⟩
Data Sources:
Market and financial statement data provided by NASDAQ, BATS Exchange, SEC and Xignite Inc. Industry and operating metrics collected from company filings via EDGAR online. For more information on sources and calculations click here.
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki